Researcher
Marine Jean Christophe
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Morphological sciences, Oncology
- See also: Chris Marine (KU Leuven)
Affiliations
- Laboratory for Molecular Cancer Biology (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - VIB-KU Leuven Center for Cancer Biology (Research Center)
Responsible
From1 Jan 2017 → Today - Marine Lab (Research group)
Responsible
From1 Jan 2017 → Today - Laboratory for Molecular Cancer Biology (VIB-KU Leuven) (Division)
Member
From1 Oct 2013 → Today - Department of Human Genetics (Department)
Member
From1 Oct 2009 → 31 Dec 2016
Projects
1 - 10 of 10
- VIB Grant for Marine Lab_Period:2022-01-01-2026-12-31From1 Jan 2022 → TodayFunding: FRI - Project driven research
- Eradicating the minimal residual disease in melanomaFrom1 Jan 2022 → TodayFunding: Other international institutions, not mentioned elsewhere
- International PhD Programme for Medical DoctorsFrom1 Jan 2022 → TodayFunding: Other EU initiatives out of framework
- 4D TUMORMAPFrom1 Jul 2021 → 30 Jun 2022Funding: Other international institutions, not mentioned elsewhere
- Understanding resistance to immune checkpoint inhibitors by mapping the tumor-host ecosystem at single-cell resolution — cellsIMPACT - marie curie individual fellowship Joanna PozniakFrom1 May 2020 → 30 Apr 2022Funding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- 'Exploring the non-genetic (i.e. ePIgenetic) mechanisms that contribute to therapy Escape in melanoma — EscaPI - Marie curie individual fellowship Aurélie BoussardFrom1 May 2020 → 30 Apr 2022Funding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Melanoma Research alliance awardFrom1 Jun 2019 → 31 May 2022Funding: Other international institutions, not mentioned elsewhere
- Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma — INHuMAN’ (marie curie individual fellowship voor Karras Panagiotis)From1 Apr 2019 → 31 Mar 2021Funding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease’ — ‘LifeTime’From1 Mar 2019 → 30 Apr 2020Funding: Other EU initiatives out of framework
- VIB Grant for Marine Lab_Period:2017-01-01-2021-12-31From1 Jan 2017 → 31 Dec 2021Funding: FRI - Project driven research
Publications
1 - 10 of 78
- Cancer Evolution: A Multifaceted Affair.(2024)
Authors: Jean-Christophe Marine
Pages: e-pub - A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma.(2024)
Authors: Joanna Pozniak, Dennis Pedri, Ewout Landeloos, Ada Nowosad, Niccolo Roda, Carlos Ariel Pulido Vicuna, Lotte Pollaris, Ruth Seurinck, Benjamin Rombaut, Frank Vernaillen, et al.
Pages: 166-183.e25 - Cell States in Cancer: Drivers, Passengers, and Trailers.(2024)
Authors: Jean-Christophe Marine
Pages: 610-614 - Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.(2024)
Authors: Joanna Pozniak, Jean-Christophe Marine
Pages: 1-23 - CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours(2023)
Authors: Joanna Pozniak, Florian Rambow, Jean-Christophe Marine
Pages: 1033-1040 - Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma.(2023)
Authors: Jelle Verhoeven, Kathryn Jacobs, Francesca Rizzollo, Francesca Lodi, Yichao Hua, Joanna Pozniak, Diede Houbaert, Sanket More, Mathieu Bertrand, Jean-Christophe Marine, et al.
Pages: e18028 - Perivascular niches: critical hubs in cancer evolution.(2023)
Authors: Ada Nowosad, Jean-Christophe Marine, Panagiotis Karras
Pages: 897-910 - STmut: a framework for visualizing somatic alterations in spatial transcriptomics data of cancer.(2023)
Authors: Joanna Pozniak, Jean-Christophe Marine
Pages: 273 - Apoptotic cell death in disease-Current understanding of the NCCD 2023.(2023)
Authors: Patrizia Agostinis, Mathieu Bertrand, Bart De Strooper, Jean-Christophe Marine, Kodimangalam Ravichandran, Peter Vandenabeele
Pages: 1097-1154 - Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.(2023)
Authors: Joanna Pozniak, Jean-Christophe Marine
Pages: eadf6621
Patents
1 - 9 of 9
- RXR ANTAGONISTS FOR USE IN MELANOMA TREATMENT (Inventor)
- MELANOMA DISEASE STRATIFICATION (Inventor)
- CD36 ANTAGONISTS FOR USE IN MELANOMA TREATMENT (Inventor)
- CD36 ANTAGONISTS FOR USE IN MELANOMA TREATMENT (Inventor)
- MELANOMA DISEASE STRATIFICATION (Inventor)
- RXR ANTAGONISTS FOR USE IN MELANOMA TREATMENT (Inventor)
- CD36 ANTAGONISTS FOR USE IN MELANOMA TREATMENT (Inventor)
- MELANOMA DISEASE STRATIFICATION (Inventor)
- RXR ANTAGONISTS FOR USE IN MELANOMA TREATMENT (Inventor)